Category: Diagnostics
Global Diagnostics
-
2024-2028 Global Methaqualone Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
2024-2028 Factor Assays Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
2024-2028 Heparin-Induced Thrombocytopenia Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
2024-2028 Global Cannabinoids/Marijuana Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Georgia, ... Read More
-
2024-2028 Prothrombin Time (PT) Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Asia-Pacific Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, ... Read More
-
2024-2028 Global Herpes Testing (Simplex I/II, Type VI) in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Regions and Countries Asia-Pacific Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, ... Read More
-
Mammography Systems Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global mammography systems market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global mammography ... Read More
-
Global Radiotherapy Market (By Technology, Procedure, Application, End User, Country Analysis), Company Profiles, Market Dynamics, Trends & Recent Developments – Forecast to 2030
... and is predicted to reach US$ 10.27 Billion by 2030. Radiotherapy, also called radiation therapy, is a medical technique used to treat cancer and some non-cancerous conditions. This non-invasive therapy can be administered externally, known ... Read More
-
Immunofluorescence Assays
... at a CAGR of 4.5% over the analysis period 2023-2030. Immunofluorescence Assays Reagents, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$3.8 Billion by the end ... Read More
-
In Vitro Diagnostics
... by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. In Vitro Diagnostics Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and ... Read More
-
Automated Immunoassay Analyzers
... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Immunofluorescence, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the ... Read More
-
Surgical Imaging Technologies
... by 2030, growing at a CAGR of 2.8% over the analysis period 2023-2030. Image Intensifier C-arms Technology, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$3.4 ... Read More
-
Teleradiology
... of 17.2% over the analysis period 2023-2030. X-ray, one of the segments analyzed in the report, is expected to record a 15.8% CAGR and reach US$5.2 Billion by the end of the analysis period. Growth ... Read More
-
Flat Panel X-Ray Detectors
... reach US$2.3 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Manufacturing Application, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach ... Read More
-
Clostridium Diagnostics
... at a CAGR of 14.1% over the analysis period 2023-2030. Immunoassays Technology, one of the segments analyzed in the report, is expected to record a 15.5% CAGR and reach US$9.1 Billion by the end of ... Read More
-
Hybrid Operating Rooms
... by 2030, growing at a CAGR of 12.2% over the analysis period 2023-2030. Cardiovascular Application, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$1.2 Billion by ... Read More
-
In-Vitro Colorectal Cancer Screening Tests
... is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record ... Read More
-
Heavy Metal Testing
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Arsenic Testing, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.1 Billion by ... Read More
-
Human Papillomavirus (HPV) Testing
... reach US$1.8 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR ... Read More
-
X-Ray Photoelectron Spectroscopy
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Healthcare End-Use, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$339.2 Million by ... Read More
-
Helicobacter Pylori Diagnostics
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$436.9 Million by ... Read More
-
Clinical Risk Grouping Solutions
... 2030, growing at a CAGR of 13.7% over the analysis period 2023-2030. Scorecard & Visualization Tools, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$1.1 Billion ... Read More
-
Multiplex Assays
... at a CAGR of 6.4% over the analysis period 2023-2030. Protein Assays, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.5 Billion by the end of ... Read More
-
Mycotoxin Testing
... at a CAGR of 5.9% over the analysis period 2023-2030. Spectroscopy- & Chromatography-Based Testing, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$1.6 Billion by the ... Read More
-
Nuclear Medicine Radioisotope
... by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Technetium-99m (Tc-99m), one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$11.7 Billion by ... Read More
Research Assistance
